NCT00635323
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +8 more
- Locations
-
- Pfizer Investigational Site Shanghai, China
- Pfizer Investigational Site Hong Kong SAR, Hong Kong
- Pfizer Investigational Site Seoul, South Korea
- Pfizer Investigational Site Seoul, South Korea